FdaApplication
NDA 213872
Identifiers
- fda_app_no: NDA213872
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE CONSUMER CARE |
| application_type | NDA |
| approval_date | 2021-06-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ASTEPRO ALLERGY | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
| CHILDREN'S ASTEPRO ALLERGY | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
2 products